| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/15/2007 | US20070037219 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof |
| 02/15/2007 | US20070037157 Socs-3 promoter methylation in cancer |
| 02/15/2007 | US20070037151 Cd4+ human papillomavirus (hpv) epitopes |
| 02/15/2007 | US20070036826 Influenza immunogen and vaccine |
| 02/15/2007 | US20070036765 determining whether a first population of human cells comprises CD34+CD38-Lin- hematopoietic stem cells isolated from normal human bone marrow, cord blood, and peripheral blood stem cell preparations |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1128813B1 An inhalation system |
| 02/14/2007 | CN1914188A Cationic substituted benzofurans as antimicrobial agents |
| 02/14/2007 | CN1913921A Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
| 02/14/2007 | CN1913920A Influenza immunogen and vaccine |
| 02/14/2007 | CN1913897A Novel compound, corresponding compositions, preparation and/or treatment methods |
| 02/14/2007 | CN1913896A Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
| 02/14/2007 | CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911921A Method for identification of tumor targeting enzymes |
| 02/14/2007 | CN1911443A Vaccine composition comprising tumor antigen and adjunvant composition |
| 02/14/2007 | CN1911230A Cancer treatment |
| 02/14/2007 | CN1911214A Method for preparing large quantity of micro-capsule |
| 02/14/2007 | CN1300232C Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 02/14/2007 | CN1299689C Application of alendronate in preparation of drug for inhibitting bone resorption |
| 02/13/2007 | US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 02/13/2007 | US7176202 Such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide; purinergic receptors (P2x7 E); for treatment of interleukin-1 associated disorders, rheumatoid arthritis |
| 02/13/2007 | US7175987 administering to mammals mixtures of plant extracts from ginger, green tea, turmeric, horseradish and carriers |
| 02/13/2007 | US7175845 providing passive immunity against ricin intoxication in a subject |
| 02/13/2007 | CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 02/13/2007 | CA2269837C Antiperspirant stick composition comprising a cross-linked or partially cross-linked non-emulsifying siloxane elastomer |
| 02/08/2007 | WO2007016679A2 Combination immediate release controlled release levodopa and carbidopa dosage forms |
| 02/08/2007 | WO2006135796A3 Crystalline forms of a pyrrolotriazine compound |
| 02/08/2007 | WO2005032453A3 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 02/08/2007 | WO2005011613A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/08/2007 | US20070032536 Compounds, compositions and methods |
| 02/08/2007 | US20070032515 Anaplastic lymphoma kinase modulators and methods of use |
| 02/08/2007 | US20070032461 1,3 Aclyated 24-keto-vitamin d3 compounds and methods of use thereof |
| 02/08/2007 | US20070032425 Compositions for diabetes treatment and prophylaxis |
| 02/08/2007 | US20070031513 Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 02/08/2007 | US20070031483 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 02/08/2007 | US20070031435 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 02/08/2007 | US20070031364 Keratin gel and the types 2,4 and 6 of collagens of frog protein topical use or for lamina preparation use, such as dressing powdering in food and complements use and in cosmetic mask manufacturing or in solutions used in cosmetic formulation and medical/pharmaceutical |
| 02/08/2007 | US20070031326 Compounds that selectively bind to membranes of apoptotic cells |
| 02/07/2007 | EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/07/2007 | EP1401813B1 New indole derivatives with 5-ht6 receptor affinity |
| 02/07/2007 | EP1141308B1 Group b streptococcus proteins, and their use |
| 02/07/2007 | EP0504363B2 PURIFIED IgG ANTIBODIES |
| 02/07/2007 | CN1909897A Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/07/2007 | CN1909782A Application of Vinpocetine and its derivant for treatment and precaution of epilepsy and its complication |
| 02/07/2007 | CN1907968A Method for making 4-(3,4-dichlorophenoxy)piperidine |
| 02/07/2007 | CN1907967A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 02/07/2007 | CN1907289A Prophylactic and therapeutic treatment of infectious and other diseases with mono and disaccharide-based compounds |
| 02/07/2007 | CN1907268A Sertraline salts and sustained-release dosage forms of sertraline |
| 02/07/2007 | CN1298322C Crystalline solids of carvedilol and processes for their preparation |
| 02/07/2007 | CN1298321C Use of phototoxicity control object of preparing medicine for restraining phototoxicity by ultraviolet radiation |
| 02/06/2007 | US7173129 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| 02/06/2007 | US7173058 For inhibiting PDE4(phosphodiesteases) in a mammal; of modulating the production of TNF- alpha; inhibiting matrix metalloproteinases, for therapy of undesired angiogenesis; therapy of cancer |
| 02/06/2007 | US7173051 Inhibitors of cathepsin S |
| 02/06/2007 | US7173036 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 02/06/2007 | US7172884 new strains of Sorangium cellulosum obtained by mutagenesis for the production of epothilones |
| 02/06/2007 | US7172875 Identifying inhibitors of intracellular protein fibrillization |
| 02/06/2007 | US7172761 Polyvalent immunogen |
| 02/01/2007 | WO2004084822A3 Methods for inducing immune tolerance |
| 02/01/2007 | US20070027138 Derivatives and analogs of galanthamine |
| 02/01/2007 | US20070027128 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour |
| 02/01/2007 | US20070027075 Compositions and methods for targeted drug delivery |
| 02/01/2007 | US20070027073 Long-acting derivatives of pyy agonists |
| 02/01/2007 | US20070027064 Pharmaceutical compositions for inhibiting metal ion dependent enzymatic activity and methods for the use thereof |
| 02/01/2007 | US20070026056 Antiviral patch |
| 02/01/2007 | US20070026018 Methods for treating, preventing and diagnosing Helicobacter infection |
| 02/01/2007 | US20070026011 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
| 02/01/2007 | US20070025989 Administration of agents for the treatment of inflammation |
| 02/01/2007 | US20070025988 Method for Treating Lupus |
| 01/31/2007 | EP1747007A1 Use of chondroitin sulphate e (cs-e ) for the treatment diseases or conditions related to collagen fibril formation. |
| 01/31/2007 | CN1906193A Oxime substituted imidazo ring compounds |
| 01/31/2007 | CN1906192A Hydroxylamine substituted imidazo ring compounds |
| 01/31/2007 | CN1906162A Hydroxy piperidine derivatives to treat gaucher disease |
| 01/31/2007 | CN1905899A EphA2 agonistic monoclonal antibodies and methods of use thereof |
| 01/31/2007 | CN1905889A A medical solution, a method for producing said medical solution and use thereof |
| 01/31/2007 | CN1905881A Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 01/31/2007 | CN1905873A Bicyclic inhibitors of MEK and methods of use thereof |
| 01/31/2007 | CN1904204A Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/31/2007 | CN1297281C Method for treatment of leukaemia |
| 01/30/2007 | US7169801 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion |
| 01/30/2007 | US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/30/2007 | US7169771 Thiazolyl-based compounds useful as kinase inhibitors |
| 01/30/2007 | US7169751 combining a compound to be tested with a 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620 polypeptide for binding of the test compound to the polypeptide; detecting binding for pain treatment |
| 01/30/2007 | US7169394 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 01/30/2007 | US7169391 Oil in water emulsions; induction immunology response; antigens |
| 01/30/2007 | CA2350573C Piperidines as ccr5 modulators |
| 01/30/2007 | CA2335495C Methods of exfoliation using n-acetyl glucosamine |
| 01/30/2007 | CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy |
| 01/30/2007 | CA2173042C Petroleum butter comprising an acyl lactylate salt |
| 01/25/2007 | WO2007011232A2 Lipid lowering agents for increasing bmd |
| 01/25/2007 | WO2007011231A2 Use of compounds comprising fatty acid entities |
| 01/25/2007 | WO2004108065A3 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies |
| 01/25/2007 | US20070021477 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/25/2007 | US20070021462 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 01/25/2007 | US20070021461 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 01/25/2007 | US20070021448 Treating an inflammatory disorder or inhibiting respiratory burst in adherent neutrophils with chemical inhibitors of neutrophil activation |
| 01/25/2007 | US20070021430 Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |